Vascular adhesion protein-1: Role in human pathology and application as a biomarker

Autor:	Marijn M. Speeckaert, Nanja van Geel, Joris R. Delanghe, Roos Pannecoeck, Lara Benmeridja, Reinhart Speeckaert, Daphne Serruys
Rok vydání:	2015
Předmět:	Amine oxidase Eye Diseases Leukocyte adhesion molecule Clinical Biochemistry Inflammation General Biochemistry Genetics and Molecular Biology medicine Diabetes Mellitus Prevalence Humans Obesity Evidence-Based Medicine Cell adhesion molecule Chemistry Biochemistry (medical) Amine oxidase (copper-containing) Soluble cell adhesion molecules Oxidative deamination Adhesion bacterial infections and mycoses Atherosclerosis respiratory tract diseases Stroke Biochemistry Amine Oxidase (Copper-Containing) medicine.symptom Cell Adhesion Molecules Biomarkers
Zdroj:	Critical reviews in clinical laboratory sciences. 52(6)
ISSN:	1549-781X
Popis:	Vascular adhesion protein-1 (VAP-1) is a member of the copper-containing amine oxidase/semicarbazide-sensitive amine oxidase (AOC/SSAO) enzyme family. SSAO enzymes catalyze oxidative deamination of primary amines, which results in the production of the corresponding aldehyde, hydrogen peroxide and ammonium. VAP-1 is continuously expressed as a transmembrane glycoprotein in the vascular wall during development and facilitates the accumulation of inflammatory cells into the inflamed environment in concert with other leukocyte adhesion molecules. The soluble form of VAP-1 is released into the circulation mainly from vascular endothelial cells. Over- and under-expression of sVAP-1 result in alterations of the reported reaction product levels, which are involved in the pathogenesis of multiple human diseases. The combination of enzymatic and adhesion capacities as well as its strong association with inflammatory pathologies makes VAP-1 an interesting therapeutic target for drug discovery. In this article, we will review the general characteristics and biological functions of VAP-1, focusing on its important role as a prognostic biomarker in human pathologies. In addition, the potential therapeutic application of VAP-1 inhibitors will be discussed.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8324493ed5c73ab92e190a28b63e34 https://pubmed.ncbi.nlm.nih.gov/26287391 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.